Skip to main content

Epilepsy clinical trials at UCSD

5 in progress, 1 open to eligible people

Showing trials for
  • FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

    open to eligible people ages 18-65

    This clinical trial is designed to test whether a single stereotactic intracerebral administration of inhibitory nerve cells into subjects with drug-resistant mesial temporal lobe epilepsy is safe (frequency of adverse events) and effective (seizure frequency).

    San Diego, California and other locations

  • Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome

    Sorry, not currently recruiting here

    The primary purpose of the study is to demonstrate that lorcaserin has superior efficacy compared to placebo on percent change in frequency of convulsive seizures per 28 days in participants with Dravet syndrome.

    San Diego, California and other locations

  • Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

    Sorry, not yet accepting patients

    The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.

    La Jolla, California and other locations

  • Cenobamate Open-Label Extension Study for YKP3089C025

    Sorry, accepting new patients by invitation only

    52 Week Open-Label Safety Study of Cenobamate for Subjects who Complete YKP3089C025 (core study)

    La Jolla, California and other locations

  • Healthy Aging in People With Epilepsy Program

    Sorry, not yet accepting patients

    The goal of this clinical trial is to develop and test an educational program about dementia in older adults living with epilepsy. The main questions it aims to answer are: 1. Can providing education on healthy aging, chronic disease management, dementia, and modifiable lifestyle dementia risk factors improve dementia knowledge and health literacy among older adults with epilepsy? 2. Can aging related education and resources improve quality of life among older adults with epilepsy? Participants will: - Complete a 12-week group educational program. - Complete pre- and post-program evaluation.

    San Diego, California

Our lead scientists for Epilepsy research studies include .

Last updated: